Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rani Therapeutics Holdings (RANI) Other Non Operating Income (2021)

Rani Therapeutics Holdings' Other Non Operating Income history spans 1 years, with the latest figure at $1.4 million for Q4 2021.

  • On a quarterly basis, Other Non Operating Income changed N/A to $1.4 million in Q4 2021 year-over-year; TTM through Dec 2022 was $700000.0, a N/A change, with the full-year FY2025 number at -$576000.0, changed N/A from a year prior.
  • Other Non Operating Income came in at $1.4 million for Q4 2021, up from -$700000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $1.4 million in Q4 2021, with the low at -$700000.0 in Q3 2021.